Patent assignee · US · COMPANY

CRITITECH, INC.

33Patents
33Active
33Granted
55Portfolio score

Filing activity: Oct 11, 2007 → Jan 29, 2024 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8778181B1 Equipment assembly for and method of processing particles Emerging Cross-Sectional Technologies 37 Active
US9814685B2 Taxane particles and their use Performing Operations; Transporting 35 Active
US7744923B2 Method for precipitation of small medicament particles into use containers Performing Operations; Transporting 33 Active
US8221779B2 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment Human Necessities 31 Active
US9233348B2 Equipment assembly for and method of processing particles Emerging Cross-Sectional Technologies 23 Active
US9918957B2 Methods for making compound particles Performing Operations; Transporting 21 Active
US10507195B2 Taxane particles and their use Performing Operations; Transporting 16 Active
US10391090B2 Methods for solid tumor treatment Human Necessities 15 Active
US10729673B2 Taxane particles and their use Performing Operations; Transporting 11 Active
US10398646B2 Methods for treating lung disorders Human Necessities 10 Active
US10507181B2 Methods for treating lung disorders Human Necessities 10 Active
US10894045B2 Methods for solid tumor treatment Human Necessities 10 Active
US9925512B2 Equipment assembly for and method of processing particles Emerging Cross-Sectional Technologies 1 Active
US10993927B2 Taxane particles and their use Performing Operations; Transporting 1 Active
US10751319B2 Collection device and methods for use Performing Operations; Transporting 1 Active
US11058639B2 Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer Chemistry; Metallurgy 1 Active
US11123322B2 Taxane particles and their use Performing Operations; Transporting 1 Active
US11033542B2 Methods for solid tumor treatment Human Necessities 1 Active
US11918691B2 Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer Chemistry; Metallurgy 0 Active
US11458133B2 Methods for solid tumor treatment Human Necessities 0 Active
US11160754B2 Methods for treating lung disorders Human Necessities 0 Active
US11738029B2 Rucaparib particles and uses thereof Human Necessities 0 Active
US11738014B2 Niraparib particles and uses thereof Human Necessities 0 Active
US12390459B2 Methods for solid tumor treatment Human Necessities 0 Active
US11931368B2 Glucocorticoid “nintedanib” particles and their use Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.